This Edition
ARTICLE | Clinical News
Cayston aztreonam: Phase III started
WIR Staff
May 2, 2005 7:00 AM UTC
Corus began the double-blind, placebo-controlled, U.S. Phase III AIR-CF2 trial in 250 patients. ...